Live Breaking News & Updates on Cardlytics Investor Relations|Page 4

Stay updated with breaking news from Cardlytics investor relations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cardlytics (NASDAQ:CDLX) Shares Down 5.7%

Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) shares traded down 5.7% on Monday . The company traded as low as $18.01 and last traded at $18.05. 138,189 shares traded hands during trading, a decline of 89% from the average session volume of 1,292,533 shares. The stock had previously closed at $19.15. Wall Street Analysts Forecast […] ....

United States , United Kingdom , Karim Saad Temsamani , Nicholas Hollmeyer Lynton , Check Capital Management Inc , American International Group Inc , Pricet Rowe Associates Inc , Needham Company , Cardlytics Inc , Jpmorgan Chase Co , Cardlytics Company Profile , Securities Exchange Commission , Get Free Report , Stock Down , Saad Temsamani , Exchange Commission , International Group , Capital Management , Pricet Rowe Associates , Cardlytics Daily , Nasdaq Cdlx , Business Service ,

Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells $1,443,783.90 in Stock

Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Karim Saad Temsamani sold 85,431 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $16.90, for a total transaction of $1,443,783.90. Following the completion of the sale, the chief executive officer now directly […] ....

United States , Hong Kong , United Kingdom , Karim Saad Temsamani , Hsbc Holdings , Cardlytics Company Profile , Cardlytics Inc , Needham Company , Tower Research Capital , Jpmorgan Chase Co , Hong Kong Ltd , Securities Exchange Commission , Get Free Report , Saad Temsamani , Exchange Commission , Trading Down , Kong Ltd , Research Capital , Cardlytics Daily , Nasdaq Cdlx , Business Service , Insider Trading , Nsider Trades ,

General Equity Holdings LP Boosts Stock Holdings in Cardlytics, Inc. (NASDAQ:CDLX)

General Equity Holdings LP increased its holdings in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) by 71.5% during the 1st quarter, HoldingsChannel reports. The fund owned 1,508,988 shares of the company’s stock after buying an additional 628,907 shares during the period. Cardlytics accounts for approximately 12.1% of General Equity Holdings LP’s portfolio, making the […] ....

United Kingdom , United States , Nicholas Hollmeyer Lynton , Karim Saad Temsamani , Potomac Capital Management Inc , Exchange Commission , Needham Company , General Equity Holdings , Equity Holdings , Cardlytics Company Profile , Pricet Rowe Associates Inc , Jpmorgan Chase Co , Cardlytics Inc , America Corp , Charles Schwab Investment Management Inc , Free Report , Capital Management , Schwab Investment Management , Stock Down , Get Free Report , Saad Temsamani , Visit Holdingschannel , Cardlytics Daily , Nasdaq Cdlx , Business Service , Sec Filings ,

Cardlytics, Inc. (NASDAQ:CDLX) Shares Bought by General Equity Holdings LP

General Equity Holdings LP lifted its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) by 71.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,508,988 shares of the company’s stock after buying an additional 628,907 shares during the period. Cardlytics comprises approximately […] ....

United States , Hong Kong , United Kingdom , Nicholas Hollmeyer Lynton , Karim Saad Temsamani , General Equity Holdings , Equity Holdings , Needham Company , Tower Research Capital , Summit Financial Strategies Inc , Securities Exchange Commission , Hong Kong Ltd , Cardlytics Inc , Jpmorgan Chase Co , Free Report , Research Capital , Kong Ltd , Summit Financial Strategies , Exchange Commission , Saad Temsamani , Get Free Report , Cardlytics Daily , Nasdaq Cdlx , Business Service , Sec Filings , Hedge Fund Holdings ,

Karim Saad Temsamani Sells 85,431 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Karim Saad Temsamani sold 85,431 shares of Cardlytics stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $16.90, for a total value of $1,443,783.90. Following the sale, the chief executive officer now owns 275,310 shares in the […] ....

United States , United Kingdom , Karim Saad Temsamani , Needham Company , Norges Bank , Jpmorgan Chase Co , Cardlytics Company Profile , Equity Holdings , Cardlytics Inc , Get Free Report , Saad Temsamani , Sigma Advisers , Montreal Can , Cardlytics Daily , Nasdaq Cdlx , Business Service , Insider Trading , Nsider Trades ,